SC
XYL icon

Sophrosyne Capital’s Xylem XYL Stock Holding History

Sophrosyne Capital’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,600
Closed -$57K – 54
2014
Q3 		$57K Hold
1,600
– – 0.07% 55
2014
Q2 		$63K Sell
1,600
-800
-33% -$29.9K 0.06% 62
2014
Q1 		$87K Sell
2,400
-2,400
-50% -$87.5K 0.08% 74
2013
Q4 		$166K Buy
+4,800
New +$154K 0.15% 53

Other funds holding XYL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
SC
Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return

Sophrosyne Capital's XYL Position: Q4 2014 in Review

Sophrosyne Capital sold out of Xylem (XYL) in Q4 2014, closing a stake of 1,600 shares — an estimated $57K sold.

Sophrosyne Capital first reported a position in XYL in Q4 2013 and held it in 4 quarters. The position peaked at $166K in Q4 2013. 435 funds tracked by Wall St. Rank hold XYL as of Q4 2014.

  • Sophrosyne Capital reported no remaining Xylem position as of Q4 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 1,600 Xylem shares in Q4 2014, an estimated $57K.
  • Sophrosyne Capital first reported a position in Xylem in Q4 2013 and held it in 4 quarters.
  • Sophrosyne Capital's Xylem position peaked at $166K in Q4 2013.
  • 435 funds tracked by Wall St. Rank held Xylem as of Q4 2014.

Based on Sophrosyne Capital's 13F filing for Q4 2014, filed 26 Jan 2015.